Patent details
EP3890833 Title: SYNERGISTIC COMPOSITIONS COMPRISING (R)-2-(2-OXOPYRROLIDIN-1-YL)BUTANAMIDE AND (S)-2-(2-OXOPYRROLIDIN-1-YL)BUTANAMIDE IN A NON-RACEMIC RATIO
Basic Information
- Publication number:
- EP3890833
- PCT Application Number:
- EP2019083594
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP198138372
- PCT Publication Number:
- WO2020115093
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- SYNERGISTIC COMPOSITIONS COMPRISING (R)-2-(2-OXOPYRROLIDIN-1-YL)BUTANAMIDE AND (S)-2-(2-OXOPYRROLIDIN-1-YL)BUTANAMIDE IN A NON-RACEMIC RATIO
- French Title of Invention:
- COMPOSITIONS SYNERGIQUES COMPRENANT (R)-2-(2-OXOPYRROLIDIN-1-YL)- BUTANAMIDE ET (S)-2-(2-OXOPYRROLIDIN-1-YL)- BUTANAMIDE DANS UN RAPPORT NON RACÉMIQUE
- German Title of Invention:
- SYNERGISTISCHE ZUSAMMENSETZUNGEN MIT (R)-2-(2-OXOPYRROLIDIN-1-YL)BUTANAMID UND (S)-2-(2-OXOPYRROLIDIN-1-YL)BUTANAMID IN EINEM NICHT-RACEMISCHEN VERHÄLTNIS
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 28/06/2023
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 05/07/2023
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 07/06/2023
- Unitary Effect Registration Date:
- 05/07/2023
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 04/12/2019
- Grant date:
- 07/06/2023
- EP Publication Date:
- 13/10/2021
- PCT Publication Date:
- 11/06/2020
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 07/06/2023
- EP B1 Publication Date:
- 07/06/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 04/12/2039
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 31/05/2023
- Name:
- Metys Pharmaceuticals AG
- Address:
- Gerbergasse 30, 4001 Basel, Switzerland (CH)
Inventor
1
- Name:
- GHELARDINI, Carla
- Address:
- Italy (IT)
2
- Name:
- FARINA, Carlo
- Address:
- Italy (IT)
3
- Name:
- DI CESARE MANNELLI, Lorenzo
- Address:
- Italy (IT)
4
- Name:
- SCHERZ, Michael
- Address:
- Switzerland (CH)
Priority
- Priority Number:
- 18210106
- Priority Date:
- 04/12/2018
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC classification:
- A61P 25/00; C07D 207/27; A61K 31/4015; A61P 25/02; A61P 25/24; A61P 25/28;
Publication
European Patent Bulletin
1
- Issue number:
- 202323
- Publication date:
- 07/06/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202331
- Publication date:
- 02/08/2023
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202332
- Publication date:
- 09/08/2023
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|